Lexaria Bioscience Stock (NASDAQ: LEXX) stock price, news, charts, stock research, profile.
Open | $3.30 |
Close | $3.13 |
Volume / Avg. | 89.75K / 194.47K |
Day Range | $3.07 - $3.35 |
52 Wk Range | 0.84 - 6.85 |
Market Cap | $49.49M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | - |
Days to Cover | 1.07 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lexaria Bioscience (NASDAQ:LEXX) through any online brokerage.
Other companies in Lexaria Bioscience’s space includes: Universe Pharmaceuticals (NASDAQ:UPC), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP) and Rani Therapeutics Hldgs (NASDAQ:RANI).
Lexaria Bioscience has a consensus price target of $11.00.
The stock price for Lexaria Bioscience (NASDAQ: LEXX) is $3.29 last updated September 5, 2024 at 7:23 PM EDT.
There are no upcoming dividends for Lexaria Bioscience.
Lexaria Bioscience’s Q4 earnings are confirmed for Monday, November 18, 2024.
There is no upcoming split for Lexaria Bioscience.
Lexaria Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.